T2 Biosystems, Inc. (NASDAQ:TTOO) Short Interest Down 12.3% in January

T2 Biosystems, Inc. (NASDAQ:TTOO) was the target of a large drop in short interest during the month of January. As of January 15th, there was short interest totalling 826,900 shares, a drop of 12.3% from the December 31st total of 942,500 shares. Based on an average daily volume of 1,080,000 shares, the short-interest ratio is currently 0.8 days. Approximately 6.6% of the company’s shares are short sold.

T2 Biosystems Price Performance

Shares of TTOO stock opened at $0.22 on Friday. The stock has a 50 day moving average price of $0.38 and a 200 day moving average price of $1.78. T2 Biosystems has a 52-week low of $0.21 and a 52-week high of $6.95.

Wall Street Analyst Weigh In

Separately, StockNews.com began coverage on shares of T2 Biosystems in a research report on Wednesday. They set a “sell” rating on the stock.

About T2 Biosystems

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.